Stock Research for AGIO

AGIO
Current Price

$82.8000


Latest Update: 2018-02-23 16:00:00

High
$ 82.8800
Low
$ 82.7500
Close
$ 82.8300
Volume
31254
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

AGIO Stock Chart & Research Data

The AGIO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AGIO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AGIO Due diligence Resources & Stock Charts

The AGIO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AGIO Detailed Price Forecast - CNN Money CNN View AGIO Detailed Summary - Google Finance
Yahoo View AGIO Detailed Summary - Yahoo! Finance Zacks View AGIO Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View AGIO Trends & Analysis - Trade-Ideas Barrons View AGIO Major Holders - Barrons
NASDAQ View AGIO Call Transcripts - NASDAQ Seeking View AGIO Breaking News & Analysis - Seeking Alpha
Spotlight View AGIO Annual Report - CompanySpotlight.com OTC Report View AGIO OTC Short Report - OTCShortReport.com
TradeKing View AGIO Fundamentals - TradeKing Charts View AGIO SEC Filings - Bar Chart
WSJ View Historical Prices for AGIO - The WSJ Morningstar View Performance/Total Return for AGIO - Morningstar
MarketWatch View the Analyst Estimates for AGIO - MarketWatch CNBC View the Earnings History for AGIO - CNBC
StockMarketWatch View the AGIO Earnings - StockMarketWatch MacroAxis View AGIO Buy or Sell Recommendations - MacroAxis
Bullish View the AGIO Bullish Patterns - American Bulls Short Pains View AGIO Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View AGIO Stock Mentions - StockTwits PennyStocks View AGIO Stock Mentions - PennyStockTweets
Twitter View AGIO Stock Mentions - Twitter Invest Hub View AGIO Investment Forum News - Investor Hub
Yahoo View AGIO Stock Mentions - Yahoo! Message Board Seeking Alpha View AGIO Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for AGIO - SECform4.com Insider Cow View Insider Transactions for AGIO - Insider Cow
CNBC View AGIO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AGIO - OTC Markets
Yahoo View Insider Transactions for AGIO - Yahoo! Finance NASDAQ View Institutional Holdings for AGIO - NASDAQ


Stock Charts

FinViz View AGIO Stock Insight & Charts - FinViz.com StockCharts View AGIO Investment Charts - StockCharts.com
BarChart View AGIO Stock Overview & Charts - BarChart Trading View View AGIO User Generated Charts - Trading View


Latest Financial News for AGIO

See what the IHS Markit Score report has to say about Agios Pharmaceuticals Inc.
Posted on Friday February 23, 2018

Agios Pharmaceuticals Inc NASDAQ/NGS:AGIO


FDA Grants Agios' (AGIO) Leukemia Candidate Priority Review
Posted on Friday February 16, 2018

FDA accepts Agios' NDA for its pipeline candidate ivosidenib (AG-120) and sets an action date of Aug 21, 2018.


FDA Accepts New Drug Application and Grants Priority Review for Ivosidenib in Relapsed or Refractory AML with an IDH1 Mutation
Posted on Thursday February 15, 2018

–PDUFA date set for August 21, 2018–. CAMBRIDGE, Mass., Feb. 15, 2018-- Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced ...


Agios (AGIO) Q4 Loss Wider Than Expected, Revenues Slump Y/Y
Posted on Thursday February 15, 2018

Agios (AGIO) reports wider-than-expected loss in the fourth quarter of 2017. Revenues fall short of expectations. The top line also declines year over year.


Brokers Set Expectations for Agios Pharmaceuticals Inc's Q1 2018 Earnings (AGIO)
The Ledger Gazette - 8 hours ago
Agios Pharmaceuticals Inc (NASDAQ:AGIO) - Equities researchers at SunTrust Banks issued their Q1 2018 EPS estimates for Agios Pharmaceuticals in a note issued to investors on Thursday, Zacks Investment Research reports.
Analysts Expect Agios Pharmaceuticals Inc (AGIO) Will Post Earnings of -$1.60 ... - StockNewsTimes
Agios Pharmaceuticals Inc (AGIO) CEO Sells $1911453.48 in Stock - Dispatch Tribunal

Is There Uncertainty On The Side Of Analysts? – Agios Pharmaceuticals, Inc ...
Post Analyst - 14 hours ago
According to 10 stock analysts, Agios Pharmaceuticals, Inc., is being kept at an average Outperform, rating, with at least 15.32% of shares outstanding that are currently legally short sold.

Agios Pharmaceuticals' (AGIO) CEO Dr. David Schenkein on Q4 2017 Results ...
Seeking Alpha - Feb 15, 2018
Good morning everyone and welcome to Agios' fourth quarter 2017 conference call. You could access slides for today's call by going to the Investors section of our website, agios.com. With me on the call today are Dr. David Schenkein, our Chief ...
Agios Reports Fourth Quarter and Full Year 2017 Financial Results - GlobeNewswire (press release)

Agios Pharmaceuticals (AGIO) Q4 Earnings: What's in Store?
Nasdaq - Feb 9, 2018
Moreover, Agios' progress with the pipeline has been quite impressive in the fourth quarter. In fact, investors' focus will remain on the same in the to-be reported quarter.
Ensign Group (ENSG) Beats on Q4 Earnings, Raises '18 View - Zacks.com

Enter a stock symbol to view the stock details.